# Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration

> **NCT02561442** · PHASE2,PHASE3 · COMPLETED · sponsor: **scPharmaceuticals, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Pharmacokinetics in Healthy Adults

## Interventions

- **DRUG:** ceftriaxone

## Key facts

- **NCT ID:** NCT02561442
- **Lead sponsor:** scPharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561442, "Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02561442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*